Aileen M. Moloney

2.0k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Aileen M. Moloney is a scholar working on Molecular Biology, Aging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Aileen M. Moloney has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Aging and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Aileen M. Moloney's work include Genetics, Aging, and Longevity in Model Organisms (3 papers), Mitochondrial Function and Pathology (2 papers) and Alzheimer's disease research and treatments (2 papers). Aileen M. Moloney is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (3 papers), Mitochondrial Function and Pathology (2 papers) and Alzheimer's disease research and treatments (2 papers). Aileen M. Moloney collaborates with scholars based in United Kingdom, Ireland and Netherlands. Aileen M. Moloney's co-authors include Rebecca J. Griffin, Rivka Ravid, Cora O’Neill, Rosemary O’Connor, Suzanne Timmons, Damian C. Crowther, Janet Johnston, Peter Dockery, Mary Kelliher and David A. Lomas and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Trends in Biochemical Sciences.

In The Last Decade

Aileen M. Moloney

9 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

2008 621 citations Aileen M. Moloney, Rebecca J. Griffin et al. Neurobiology of Aging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aileen M. Moloney United Kingdom	8	805	673	354	219	215	9	1.6k
Yoshio Namba Japan	16	1.3k 1.6×	778 1.2×	349 1.0×	246 1.1×	189 0.9×	28	1.9k
Carmela Matrone Italy	24	625 0.8×	668 1.0×	509 1.4×	105 0.5×	194 0.9×	49	1.7k
Konstantinos Vekrellis United States	7	1.2k 1.5×	823 1.2×	348 1.0×	126 0.6×	274 1.3×	7	1.8k
Zhongmin Xiang United States	16	769 1.0×	536 0.8×	357 1.0×	102 0.5×	156 0.7×	23	1.6k
Erika Bereczki Sweden	22	623 0.8×	510 0.8×	280 0.8×	192 0.9×	164 0.8×	40	1.4k
Liana Fidani Greece	18	1.3k 1.6×	927 1.4×	449 1.3×	458 2.1×	287 1.3×	74	2.2k
Paige E. Cramer United States	7	1.2k 1.4×	785 1.2×	379 1.1×	154 0.7×	262 1.2×	7	2.0k
Patricia A. Gonzalez‐DeWhitt United States	13	1.1k 1.3×	823 1.2×	260 0.7×	88 0.4×	197 0.9×	19	1.7k
Ryan T. Hamilton United States	15	767 1.0×	801 1.2×	214 0.6×	101 0.5×	135 0.6×	19	1.6k

Countries citing papers authored by Aileen M. Moloney

Since Specialization

Citations

This map shows the geographic impact of Aileen M. Moloney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen M. Moloney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen M. Moloney more than expected).

Fields of papers citing papers by Aileen M. Moloney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen M. Moloney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen M. Moloney. The network helps show where Aileen M. Moloney may publish in the future.

Co-authorship network of co-authors of Aileen M. Moloney

This figure shows the co-authorship network connecting the top 25 collaborators of Aileen M. Moloney. A scholar is included among the top collaborators of Aileen M. Moloney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen M. Moloney. Aileen M. Moloney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Khabirova, Eleonora, Aileen M. Moloney, Stefan J. Marciniak, et al.. (2014). The TRiC/CCT Chaperone Is Implicated in Alzheimer's Disease Based on Patient GWAS and an RNAi Screen in Aβ-Expressing Caenorhabditis elegans. PLoS ONE. 9(7). e102985–e102985. 29 indexed citations

Murakami, Tetsuro, Seung‐Pil Yang, Lin Xie, et al.. (2011). ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Human Molecular Genetics. 21(1). 1–9. 102 indexed citations

Malzer, Elke, Aileen M. Moloney, Sally E. Thomas, et al.. (2010). Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response. Journal of Cell Science. 123(17). 2892–2900. 33 indexed citations

Moloney, Aileen M., Sarah Meehan, Kyle L. Morris, et al.. (2010). Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation. Journal of Biological Chemistry. 286(6). 4248–4256. 183 indexed citations

Moloney, Aileen M., David B. Sattelle, David A. Lomas, & Damian C. Crowther. (2009). Alzheimer's disease: insights from Drosophila melanogaster models. Trends in Biochemical Sciences. 35(4). 228–235. 100 indexed citations

Timmons, Suzanne, et al.. (2009). Akt signal transduction dysfunction in Parkinson's disease. Neuroscience Letters. 467(1). 30–35. 154 indexed citations

Moloney, Aileen M., Rebecca J. Griffin, Suzanne Timmons, et al.. (2008). Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiology of Aging. 31(2). 224–243. 621 indexed citations breakdown →

Moloney, Aileen M., Rebecca J. Griffin, Meghan F. Coakley, et al.. (2008). P4‐222: Defects in IGF‐1 receptor, insulin receptor and insulin receptor substrate proteins in Alzheimer's disease neurons indicate resistance to insulin and IGF‐1 signaling. Alzheimer s & Dementia. 4(4S_Part_23). 1 indexed citations

Griffin, Rebecca J., Aileen M. Moloney, Mary Kelliher, et al.. (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. Journal of Neurochemistry. 93(1). 105–117. 393 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact